VALENTINO, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 3.658
AS - Asia 2.559
EU - Europa 906
SA - Sud America 756
AF - Africa 61
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 7.947
Nazione #
US - Stati Uniti d'America 3.523
SG - Singapore 1.185
CN - Cina 582
BR - Brasile 581
IT - Italia 337
VN - Vietnam 331
IN - India 248
GB - Regno Unito 131
SE - Svezia 121
DE - Germania 109
CA - Canada 100
AR - Argentina 75
FI - Finlandia 52
HK - Hong Kong 37
ID - Indonesia 34
EC - Ecuador 33
BD - Bangladesh 32
RU - Federazione Russa 29
UA - Ucraina 22
NL - Olanda 21
MX - Messico 19
ZA - Sudafrica 19
CO - Colombia 17
PK - Pakistan 16
IQ - Iraq 15
JP - Giappone 15
FR - Francia 14
PL - Polonia 13
VE - Venezuela 13
CL - Cile 12
ES - Italia 10
MA - Marocco 10
RO - Romania 10
PY - Paraguay 9
EG - Egitto 8
UY - Uruguay 8
SA - Arabia Saudita 7
TN - Tunisia 7
AT - Austria 6
PE - Perù 6
TR - Turchia 6
AE - Emirati Arabi Uniti 5
DO - Repubblica Dominicana 5
IE - Irlanda 5
JM - Giamaica 5
NP - Nepal 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CZ - Repubblica Ceca 4
EE - Estonia 4
JO - Giordania 4
KE - Kenya 4
CR - Costa Rica 3
DZ - Algeria 3
IR - Iran 3
KR - Corea 3
PH - Filippine 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
AO - Angola 2
AU - Australia 2
BO - Bolivia 2
ET - Etiopia 2
EU - Europa 2
GR - Grecia 2
IL - Israele 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
MK - Macedonia 2
PT - Portogallo 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CU - Cuba 1
GA - Gabon 1
GE - Georgia 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
SV - El Salvador 1
TH - Thailandia 1
TV - Tuvalu 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.947
Città #
San Jose 633
Chandler 442
Singapore 341
Dallas 315
Ashburn 306
Santa Clara 207
Bengaluru 185
Hefei 183
Milan 153
Lawrence 149
Princeton 149
Ho Chi Minh City 126
Chicago 110
London 108
Munich 87
Beijing 75
Wilmington 75
Hanoi 74
Ottawa 74
Des Moines 59
Boardman 48
São Paulo 44
Turku 35
Hong Kong 34
Los Angeles 26
Shanghai 21
Guangzhou 19
New York 17
Haiphong 16
Brasília 15
Helsinki 15
Hải Dương 14
Norwalk 14
San Francisco 14
Shenzhen 14
Chennai 13
Orem 13
Rio de Janeiro 13
Salvador 13
The Dalles 13
Catanzaro 12
Curitiba 12
Quito 12
Rossano 12
Amsterdam 11
Brooklyn 11
Guayaquil 11
Augusta 10
Rome 10
Secaucus 10
Thái Bình 10
Tokyo 10
Campinas 9
Da Nang 9
Pune 9
Warsaw 9
Aversa 8
Biên Hòa 8
New Delhi 8
Quảng Ngãi 8
Belo Horizonte 7
Boston 7
Buffalo 7
Council Bluffs 7
Johannesburg 7
Montevideo 7
Stockholm 7
Toronto 7
Atlanta 6
Baghdad 6
Bắc Giang 6
Caracas 6
Columbus 6
Horia 6
Lahore 6
Manaus 6
Porto Alegre 6
Rui'an 6
Xian 6
Diadema 5
Genoa 5
Jakarta 5
Jeddah 5
Jiaxing 5
Medellín 5
Mexico City 5
Ninh Bình 5
Redmond 5
Seattle 5
Sorocaba 5
Ann Arbor 4
Asunción 4
Bogotá 4
Boydton 4
Buenos Aires 4
Cabo Frio 4
Can Tho 4
Cape Town 4
Corrientes 4
Dhaka 4
Totale 4.678
Nome #
Microstructural alterations of the spinothalamic tract and neuropathic pain: A diffusion tensor imaging study in relapsing remitting multiple sclerosis 115
PRECLINICAL MARKERS OF NEUROPATHIC DAMAGE IN TYPE 1 DIABETES MELLITUS 98
A new locus for autosomal dominant nocturnal frontal lobe epilepsy maps to chomosome 1 93
A new locus for autosomal dominant nocturnal frontal lobe epilepsy maps to chromosome 1 84
A. Spinal muscular atrophy due to an isolated deletion of Exon 8 of telomeric survival motor neuron gene 81
Varicella zoster immunity loss in multiple sclerosis patient treated with ocrelizumab 78
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 75
Efficacy of Transcranial Direct Current Stimulation (tDCS) on Balance and Gait in Multiple Sclerosis Patients: A Machine Learning Approach 71
Spinal muscular atrophy due to an isolated deletion of exon 8 of the telomeric survival motor neuron gene 71
A case of facioscapulohumeral muscular dystrophy and myasthenia gravis with positivity of anti-Ach receptor antibody: a fortuitous association? 69
Assessment of the Corticospinal Tract Profile in Pure Lower Motor Neuron Disease: A Diffusion Tensor Imaging Study 69
Calf pseudohypertrophy in a patient with double neurogenic pathology 67
Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: A 18-month multicentre study 66
Humoral and T-cell response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients: Correlations with DMTs and clinical variables 65
Fatigue in natalizumab-treated Multiple Sclerosis patients: How much is wearing-off to blame? 64
Anti-GAD associated inflammatory myopathy presenting with dropped head syndrome 64
Blink reflex recovery cycle in patients with dystonic tremor: a cross-sectional study 63
Idiopathic generalized epilepsy in a family with SCN4A-related myotonia 62
Lamotrigine therapy for paroxysmal dysarthria caused by multiple sclerosis: a case report. 61
An axon regeneration signature in a Charcot-Marie-Tooth disease type 2 patient. 60
Administration of subcutaneous interferon beta 1a in the evening: data from RELIEF study 60
A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide. 59
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 59
Evaluation of machine learning algorithms performance for the prediction of early multiple sclerosis from resting-state FMRI connectivity data 58
Genetics heterogeneity in patients with pantothenate kinase-associated neurodegeneration and classic magnetic resonance imaging eye-of-the-tiger pattern 58
Listeria infection after treatment with alemtuzumab: A case report and literature review. would antibiotic prophylaxis be considered? 57
Adaptive cortical changes and the functional correlates of visuo-motor integration in relapsing-remitting multiple sclerosis 56
Computer-assisted cognitive rehabilitation of attention deficits for multiple sclerosis: a randomized trial with fMRI correlates 56
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial 56
Superior Cerebellar Peduncle Atrophy Predicts Cognitive Impairment in Relapsing Remitting Multiple Sclerosis Patients with Cerebellar Symptoms: A DTI Study 55
Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients 55
TARDBP gene mutations in south Italian patients with amyotrophic lateral sclerosis. 55
Palatal tremor in a patient with primary intestinal lymphoma 55
The one-and-a-half syndrome: a distinctive clinical finding in a patient with multiple sclerosis 54
Two cases of unilateral wasting and weakness of distal upper limb: Similar onset and different diagnosis in young patients 54
Alterazioni istopatologiche ed ultrastrutturali nel connettivo subsinoviale nella sindrome del tunnel carpale idiopatica 54
Action palatal tremor in a patient with primary intestinal lymphoma 54
LACK OF ASSOCIATION BETWEEN ESTROGEN RECEPTOR 1 GENE POLYMORPHISMS AND MULTIPLE SCLEROSIS IN SOUTHERN ITALY IN HUMANS 54
Thalamic tremor as onset of vascular parkinsonism 54
Randomized trial comparing two different high doses of methylprednisolone in MS: a clinical and MRI study 53
A novel Angiogenin gene mutation in a sporadic patient with amyotrophic lateral sclerosis from southern Italy 53
Alternating pattern distinguishes resting tremor of Parkinson’s disease from rest tremor associated with essential tremor 53
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis 53
Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis 53
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 52
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic 52
Kufs’ disease presenting as late-onset epilepsia partialis continua 52
Responsiveness of clinical outcome measures in Charcot-Marie-Tooth disease. 52
Negative myoclonus during valproate-related stupor. Neurophysiological evidence of a cortical non-epileptic origin. 51
Camptocormia as presenting in lower motor neuron disease with TARDBP mutation: case report. 51
Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells 50
Autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths: clinical, electrophysiologic, and genetic aspects of a large family. 50
ACTION PALATAL TREMOR IN PATIENT WITH PRIMARY INTESTINAL LYMPHOMA 50
Blink reflex recovery cycle in patients with essential tremor associated with resting tremor. 50
Temporal lobe epilepsy as a unique manifestation of multiple sclerosis 50
Anti-GM1 antibodies are not associated with cerebral atrophy in patients with multiple sclerosis 50
PMP22 messenger RNA levels in skin biopsies: testing the effectiveness of a Charcot-Marie-Tooth 1A biomarker. 49
Tractography in amyotrophic lateral sclerosis using a novel probabilistic tool: A study with tract-based reconstruction compared to voxel-based approach 49
The corticospinal tract profile in amyotrophic lateral sclerosis 48
Blink reflex recovery cycle distinguishes essential tremor with resting tremor from de novo Parkinson's disease 48
CAG repeat length and clinical features in three Italian families with spinocerebellar ataxia type 2 (SCA2): early impairment of Wisconsin Card Sorting Test and saccade velocity 48
The effects of BDNF Val66Met polymorphism on brain fuction in controls and patients with multiple sclerosis: an imaging genetic study. 48
Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis 48
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study 47
Somatosensory evoked potentials reflect the upper limb motor performance in multiple sclerosis 47
Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic 46
Individual differences in depression are associated with abnormal function of the limbic system in multiple sclerosis patients 46
A new SBF2 mutation in a family with recessive demielinating Charcot-Marie-Tooth (CMT4B2) 46
Clinical and genetic study of a large Charcot-Marie-Tooth type 2A family from southern Italy 46
Autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths 46
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience 46
CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab 46
Genetic screening for familial amyloid polyneuropathy in patients with idiopathic carpal tunnel syndrome 45
Genetic heterogeneity in autosomal recessive hereditary motor and sensory neuropathy with focally folded myelin sheaths (CMT4B) 45
Sporadic ALS is not associated with VAPB gene mutations in Southern Italy 45
Neurobiological mechanisms underlying emotional processing in relapsing-remitting multiple sclerosis 45
Investigating the role of brain-derived neurotrophic factor in relapsing-remitting multiple sclerosis 45
A multicenter retrospective study of charcot-marie-tooth disease type 4B (CMT4B) associated with mutations in myotubularin-related proteins (MTMRs) 45
Clinical and genetic study of a large Charcot-Marie-Tooth type 2° family southern Italy 44
Synchronous pattern distinguishes resting tremor associated with essential tremor from rest tremor of Parkinson's disease 44
Cognitive deficits in multiple sclerosis patients with cerebellar symptoms 44
A novel Notch3 gene mutation not involving a cysteine residue in an Italian family with CADASIL 44
Brain atrophy and lesion load in a large population of patients with multiple sclerosis 44
NOS2A as a candidate gene in Relapsing-Remitting Multiple Sclerosis: a haplotype study using selected subsets of single nucleotide polymorphisms 44
Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study 43
The relationship between regional microstructural abnormalities of the corpus callosum and physical and cognitive disability in relapsing-remitting multiple sclerosis 43
GENETIC HETEROGENEITY IN AUTOSOMAL RECESSIVE HEREDITARY MOTOR AND SENSORY NEUROPHATY WITH FOCALLY FOLDED MYELIN SHEATHS (CMT4B) 43
A Cellular Neural Network methodology for the automated segmentation of multiple sclerosis lesions. 43
Histopathological, Clinical, and Electrophysiological Features Influencing Postoperative Outcomes in Carpal Tunnel Syndrome 43
An exploration of anger phenomenology in multiple sclerosis. 43
Correction to: Daytime sleepiness and sleep quality in Charcot–Marie–Tooth disease 42
Relationship between clinical examination, quality of life, disability and depression in CMT patients: Italian multicenter study 42
Reliability of clinical outcome measures in Charcot-Marie-Tooth disease 42
The BDNF Val66Met polymorphism has opposite effects on memory circuits of multiple sclerosis patients and controls. 42
HYPEREKPLEXIA IN PATIENT WITH A BRAINSTEM VASCULAR ANOMALY 42
mpairment of acquired color vision in multiple sclerosis: an early diagnostic sign linked to the greatness of disease. 42
Clinical spectrum and frequency of Charcot–Marie–Tooth disease in Italy: Data from the National CMT Registry 41
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study 41
An unusual ALS onset with hyperhidrosis as first clinical manifestation 41
Cerebellar-parietal dysfunctions in multiple sclerosis patients with cerebellar signs. 41
Totale 5.376
Categoria #
all - tutte 74.585
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.585


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 0 0 0 0 0 0 29 2 2
2021/2022327 2 2 1 82 37 3 8 79 30 17 64 2
2022/20231.202 309 26 32 133 161 116 1 76 173 74 75 26
2023/2024497 111 79 47 27 30 135 23 4 3 10 2 26
2024/20251.819 231 114 110 76 129 225 33 68 250 120 160 303
2025/20263.973 196 460 552 850 396 123 499 235 505 157 0 0
Totale 8.127